April 24, 2018
Onxeo Announces Initiation of DRIIV Phase I Clinical Trial of AsiDNA™ for Treatment of Advanced Solid Tumor
Media
April 23, 2018
MIPS receives a positive decision in European patent case
April 20, 2018
Nexstim Plc to present at BioTrinity 2018 in London
April 19, 2018
MIPS and POC Sweden have reached a settlement and will strengthen their cooperation
April 16, 2018
Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 American Association of Cancer Research (AACR) Annual Meeting in Chicago
April 16, 2018
Nordic Nanovector Presents Preclinical Data at AACR 2018
April 12, 2018
Targovax strengthens Board of Directors with the appointment of Catherine Wheeler
April 12, 2018
First patient starts treatment in Oncopeptides’ Phase I / II ANCHOR study with Ygalo®
April 12, 2018
Promising preliminary long-term data for WTX101 in Wilson Disease presented at EASL Annual Meeting
April 11, 2018
Statement by the Independent Committee of the Board of Directors of Wilson Therapeutics in relation to the public offer from Alexion
